Proactive Investors - Run By Investors For Investors

Chemistree Technology adds cannabis exec Nicholas Zitelli to board

Zitelli is now the part-owner and chief cannabis officer of Trans High Corporation, the parent company of the 45-year-old High Times magazine
medicinal cannabis and Rx sheet
Chemistree is an investment company focused on acquiring and developing cannabis assets in the US and Canada

Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) announced Tuesday that it has succeeded in recruiting a seasoned cannabis industry executive Nicholas Zitelli to its board of directors.

Zitelli is now the part-owner, director and chief cannabis officer of Trans High Corporation, the parent company of the 45-year-old High Times magazine. He’s also the founder and CEO of the Cannabis Genetics Institute, a research and development institute focused on the breeding of medicinal cannabis, set up in Amsterdam in 2014.

READ: Chemistree Technology ‘confident’ of being granted Desert Hot Springs permit for its new cannabis facility

Most recently, he was also named CEO of the newly-formed group Applied Cannabis Sciences LLC, which aims to acquire and operate medical marijuana licenses in the Eastern US and boasts projects in New Jersey, New York and Massachusetts. And he's also written hundreds of articles covering a range of topics in cannabis science under the pen name Nico Escondido.

“These are exciting times for the company and Mr. Zitelli will be a truly outstanding addition to our board of directors,” said Karl Kottmeier, in a statement. “His worldwide network through the professional cannabis community, in addition to his excellent reputation, will unquestionably be invaluable assets to our company’s continued growth.”

For his part, Zitelli says he is looking forward to joining Chemistree as it widens its reach.

“I appreciate the opportunity to support Chemistree through the Company's planned expansion, particularly in the US market, and help it to define the future of the cannabis industry,” he said in a statement.

Headquartered in Vancouver, Chemistree is an investment company focused on acquiring and developing cannabis assets in the US and Canada.

Chemistree shares slipped C$0.01 to trade at C$0.60 on Monday.

Contact Ellen Kelleher at [email protected]

-- This story is updated to reflect latest share price movement -- 

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
A cannabis facility
January 10 2019
The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site
cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use